ARDT (Ardent Health, Inc.) Stock Analysis - Analyst Ratings

Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.65 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ARDT?

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.59.

ARDT Key Metrics

Key financial metrics for ARDT
MetricValue
Price$9.65
Market Cap$1.45B
P/E Ratio9.87
EPS$0.96
Dividend Yield0.00%
52-Week High$20.72
52-Week Low$8.07
Volume344.89K
Avg Volume0
Revenue (TTM)$6.32B
Net Income$230.13M
Gross Margin0.00%

ARDT Analyst Consensus

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.

Latest ARDT News

Recent ARDT Insider Trades

  • Webb Robert Thomas bought 10.00K (~$174.70K) on Nov 8, 2024.
  • Webb Robert Thomas bought 10.00K (~$164.90K) on Nov 8, 2024.

Common questions about ARDT

What do analysts rate ARDT?
10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.59.
Does Rallies show ARDT price targets?
Yes. Rallies tracks ARDT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ARDT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.
ARDT

ARDT